Drug Industry Seeks Ways to Capitalize on Election Success. Drug companies are devising ways to capitalize on their electoral success by securing favorable new legislation. By Robert Pear and Richard A. Oppel Jr.. [New York Times: Business]


Posted

in

by

Tags: